Although our analysis of TGFβ2 in AH (Figure 7B) and at the iridocorneal angle (Figure 7F) were not statistically significant, separate analysis of ocular hypertensive eyes (Figure 7C,G) demonstrated that active TGFβ2 levels were significantly elevated in AH (by 4.78-fold) and in anterior segments (by 93.96%) of LV_TGFβ2-treated eyes. Here, TGFB2 is linked to ocular hypertension.